Credit Suisse’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $30.9M | Sell |
141,459
-5,975
| -4% | -$1.32M | 0.03% | 518 |
|
|
2023
Q4 | $33.5M | Buy |
147,434
+4,045
| +3% | +$850K | 0.03% | 505 |
|
|
2023
Q3 | $28.8M | Sell |
143,389
-23,498
| -14% | -$4.96M | 0.03% | 539 |
|
|
2023
Q2 | $34.6M | Sell |
166,887
-9,996
| -6% | -$1.94M | 0.03% | 500 |
|
|
2023
Q1 | $34.9M | Sell |
176,883
-4,276
| -2% | -$880K | 0.04% | 512 |
|
|
2022
Q4 | $36.6M | Sell |
181,159
-156,278
| -46% | -$30.5M | 0.04% | 489 |
|
|
2022
Q3 | $59.4M | Sell |
337,437
-1,970
| -0.6% | -$403K | 0.07% | 317 |
|
|
2022
Q2 | $68.3M | Buy |
339,407
+132,648
| +64% | +$28.3M | 0.07% | 291 |
|
|
2022
Q1 | $46.8M | Sell |
206,759
-164,629
| -44% | -$38.7M | 0.04% | 462 |
|
|
2021
Q4 | $100M | Buy |
371,388
+17,503
| +5% | +$4.33M | 0.05% | 359 |
|
|
2021
Q3 | $85.6M | Buy |
353,885
+82,439
| +30% | +$20.8M | 0.05% | 420 |
|
|
2021
Q2 | $64.4M | Buy |
271,446
+45,971
| +20% | +$10.5M | 0.03% | 560 |
|
|
2021
Q1 | $49.4M | Buy |
225,475
+29,092
| +15% | +$5.84M | 0.03% | 710 |
|
|
2020
Q4 | $34.3M | Sell |
196,383
-34,247
| -15% | -$5.92M | 0.02% | 877 |
|
|
2020
Q3 | $37.3M | Buy |
230,630
+23,366
| +11% | +$3.7M | 0.02% | 728 |
|
|
2020
Q2 | $29.6M | Buy |
207,264
+1,931
| +0.9% | +$267K | 0.02% | 762 |
|
|
2020
Q1 | $22.3M | Sell |
205,333
-62,184
| -23% | -$8.96M | 0.02% | 785 |
|
|
2019
Q4 | $38.9M | Buy |
267,517
+101,916
| +62% | +$14.7M | 0.03% | 683 |
|
|
2019
Q3 | $23.9M | Buy |
165,601
+13,757
| +9% | +$2.01M | 0.02% | 807 |
|
|
2019
Q2 | $22.6M | Sell |
151,844
-50,633
| -25% | -$7.06M | 0.02% | 854 |
|
|
2019
Q1 | $26.6M | Sell |
202,477
-13,996
| -6% | -$1.72M | 0.02% | 709 |
|
|
2018
Q4 | $23.5M | Sell |
216,473
-1,963
| -0.9% | -$263K | 0.02% | 712 |
|
|
2018
Q3 | $32.6M | Buy |
218,436
+4,975
| +2% | +$757K | 0.03% | 616 |
|
|
2018
Q2 | $32.9M | Sell |
213,461
-19,028
| -8% | -$2.87M | 0.03% | 574 |
|
|
2018
Q1 | $32.3M | Buy |
232,489
+17,511
| +8% | +$2.57M | 0.03% | 605 |
|
|
2017
Q4 | $29.5M | Buy |
214,978
+22,158
| +11% | +$2.93M | 0.03% | 667 |
|
|
2017
Q3 | $25M | Buy |
192,820
+10,606
| +6% | +$1.41M | 0.02% | 705 |
|
|
2017
Q2 | $24.1M | Sell |
182,214
-30,057
| -14% | -$3.68M | 0.02% | 710 |
|
|
2017
Q1 | $26.2M | Buy |
212,271
+3,387
| +2% | +$401K | 0.02% | 698 |
|
|
2016
Q4 | $23M | Buy |
208,884
+16,958
| +9% | +$1.88M | 0.02% | 736 |
|
|
2016
Q3 | $22.7M | Sell |
191,926
-2,484
| -1% | -$293K | 0.02% | 757 |
|
|
2016
Q2 | $21.8M | Sell |
194,410
-175,804
| -47% | -$18.9M | 0.02% | 721 |
|
|
2016
Q1 | $37.3M | Sell |
370,214
-231,454
| -38% | -$22.2M | 0.04% | 461 |
|
|
2015
Q4 | $63.9M | Buy |
601,668
+375,097
| +166% | +$38.7M | 0.07% | 288 |
|
|
2015
Q3 | $21.1M | Buy |
226,571
+14,132
| +7% | +$1.46M | 0.03% | 704 |
|
|
2015
Q2 | $22.1M | Buy |
212,439
+901
| +0.4% | +$93.8K | 0.02% | 797 |
|
|
2015
Q1 | $22.9M | Sell |
211,538
-482,668
| -70% | -$49.6M | 0.02% | 751 |
|
|
2014
Q4 | $64.4M | Buy |
694,206
+492,137
| +244% | +$43.5M | 0.06% | 358 |
|
|
2014
Q3 | $17.7M | Sell |
202,069
-12,759
| -6% | -$1.15M | 0.01% | 972 |
|
|
2014
Q2 | $18.9M | Buy |
214,828
+7,816
| +4% | +$677K | 0.02% | 970 |
|
|
2014
Q1 | $17.5M | Sell |
207,012
-14,267
| -6% | -$1.14M | 0.02% | 905 |
|
|
2013
Q4 | $17.4M | Buy |
221,279
+28,000
| +14% | +$2.39M | 0.02% | 898 |
|
|
2013
Q3 | $16.5M | Sell |
193,279
-61,311
| -24% | -$5.16M | 0.02% | 850 |
|
|
2013
Q2 | $21.9M | Buy |
+254,590
| New | +$21.1M | 0.02% | 724 |
|
Other funds holding LH
Credit Suisse's LH Position: Q1 2024 in Review
Credit Suisse reduced its Labcorp (LH) stake by 4.1% in Q1 2024, selling an estimated $1.32M and leaving 141,459 shares worth $30.9M. The position accounts for 0.03% of the portfolio, ranked #518.
Credit Suisse first reported a position in LH in Q2 2013 and has held it in 44 quarters since. The position peaked at $100M in Q4 2021. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.
- Credit Suisse held 141,459 shares of Labcorp worth $30.9M as of Q1 2024.
- Credit Suisse sold 5,975 Labcorp shares in Q1 2024, an estimated $1.32M.
- Labcorp made up 0.03% of Credit Suisse's portfolio in Q1 2024, its #518 holding.
- Credit Suisse first reported a position in Labcorp in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Labcorp position peaked at $100M in Q4 2021.
- 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.